References
- Drummond MF, Sculpher MJ, Torrance G, et al. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford University Press, 2005
- Drummond MF, Schwartz JS, Jönsson B, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care 2008;24:244–58
- Rennie D, Luft HS. Pharmacoeconomic analyses. JAMA 2000;283:2158–60
- Neumann PJ, Stone PW, Chapman RH, et al. The quality of reporting in published cost-utility analyses, 1976-1997. Ann Intern Med 2000;132:964
- Rosen AB, Greenberg D, Stone PW, et al. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Making 2005;25:424–8
- Turner L, Shamseer L, Altman DG, et al. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev 2012;1:60
- Drummond MF. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing? Pharmacoeconomics 1998;14:1–9
- McGhan WF, Al M, Doshi JA, et al. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force report. Value Health 2009;12:1086–99
- Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology. A report on principles. Ann Intern Med 1995;123:61–70
- Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275–83
- Gold MR. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
- Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1339–41
- Nuijten MJ, Pronk MH, Brorens MJ, et al. Reporting format for economic evaluation: Part II: focus on modelling studies. Pharmacoeconomics 1998;14:259–68
- Vintzileos AM, Beazoglou T. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics. Am J Obstet Gynecol 2004;191:1070–6
- Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 2005;21:165–71
- Ramsey S, Willke R, Briggs A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005;8:521–33.
- Goetghebeur MM, Wagner M, Khoury H, et al. Evidence and value: impact on decisionmaking—the EVIDEM framework and potential applications. BMC Health Serv Rev 2008;8:270
- Davis JC, Robertson MC, Comans T, et al. Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int 2010;22:2449–59
- Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ 2011;342:d1766
- Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ 2011;342:d1548
- Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and elaboration: a Report of the ISPOR Health Economic Evaluations Publication Guidelines Good Reporting Practices Task Force. Value Health 2013;16:231–50
- Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7:e1000217
- Moher D, Weeks L, Ocampo M, et al. Describing reporting guidelines for health research: a systematic review. J Clin Epi 2011;64:718–42
- Campbell SM, Hann M, Roland MO, et al. The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Med Care 1999;37:964–8